Related Experiment Video
Updated: Dec 14, 2025
04:55
Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model
Published on: May 26, 2023
1.2K
Sugammadex: Applications in Pediatric Critical Care
Joseph D Tobias1,2,3
1Department of Anesthesiology and Pain Medicine, Nationwide Children's Hospital, Columbus, Ohio, United States.
Journal of Pediatric Intensive Care
|July 21, 2020
Summary
Sugammadex offers a novel approach to reversing neuromuscular blockade in pediatric patients, showing faster and more complete results than traditional methods. It is effective even in complex cases, including those with intense blockade or contraindications to other drugs.
Area of Science:
- Anesthesiology
- Pharmacology
Background:
- Neuromuscular blockade is common in pediatric anesthesia and intensive care.
- Acetylcholinesterase inhibitors (e.g., neostigmine) are standard reversal agents but have limitations.
- Sugammadex presents a novel mechanism for neuromuscular blockade reversal.
Purpose of the Study:
- To review the physiology of neuromuscular transmission.
- To summarize the literature on sugammadex use in the pediatric population.
- To discuss clinical applications, adverse effects, and dosing of sugammadex in pediatrics.
Main Methods:
- Literature review of published studies on sugammadex in pediatric patients.
- Analysis of prospective trials comparing sugammadex with acetylcholinesterase inhibitors.
- Inclusion of data from pediatric intensive care unit populations.
Main Results:
- Sugammadex demonstrates more rapid and complete reversal of rocuronium-induced blockade compared to neostigmine.
- It effectively reverses intense or complete neuromuscular blockade.
- Potential efficacy in patients with neuromyopathic conditions or when acetylcholinesterase inhibitors are contraindicated.
Conclusions:
- Sugammadex is a safe and effective agent for reversing neuromuscular blockade in pediatric patients.
- Its unique mechanism offers advantages over traditional agents, especially in specific clinical scenarios.
- Further research supports its expanding role in pediatric anesthesia and critical care.
More Related Videos
Related Concept Videos
01:24Parenteral Anesthetics: Overview
479
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
479
01:19Depolarizing Blockers: Pharmocokinetics
507
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
507
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
131
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
131
01:31Skeletal Muscle Relaxants: Therapeutic Uses
795
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
795
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
114
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
114
01:29Drug Dosing: Infants and Children
154
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
154